These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 14727021)

  • 61. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Godet G
    Lancet; 2001 Aug; 358(9281):581; author reply 582. PubMed ID: 11526922
    [No Abstract]   [Full Text] [Related]  

  • 62. Renal impact of fluid management with colloids.
    Boldt J
    Eur J Anaesthesiol; 2007 Oct; 24(10):891-2. PubMed ID: 17977100
    [No Abstract]   [Full Text] [Related]  

  • 63. The SSAI fully supports the suspension of hydroxyethyl-starch solutions commissioned by the European Medicines Agency.
    Laake JH; Tønnessen TI; Chew MS; Lipcsey M; Hjelmqvist H; Wilkman E; Pettilä V; Hoffmann-Petersen J; Møller MH;
    Acta Anaesthesiol Scand; 2018 Jul; 62(6):874-875. PubMed ID: 29658984
    [No Abstract]   [Full Text] [Related]  

  • 64. Hydroxyethyl starch: putting patient safety first.
    Bion J; Bellomo R; Myburgh J; Perner A; Reinhart K; Finfer S
    Intensive Care Med; 2014 Feb; 40(2):256-259. PubMed ID: 24352482
    [No Abstract]   [Full Text] [Related]  

  • 65. Update: New England Journal of Medicine publishes correction to 2012 CHEST trial of hydroxyethyl starch versus colloids.
    Doshi P
    BMJ; 2016 Mar; 352():i1571. PubMed ID: 27001086
    [No Abstract]   [Full Text] [Related]  

  • 66. Hydroxyethyl starch.
    Treib J; Haass A
    J Neurosurg; 1997 Mar; 86(3):574-5. PubMed ID: 9046322
    [No Abstract]   [Full Text] [Related]  

  • 67. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Boldt J
    Lancet; 2001 Aug; 358(9281):581-3. PubMed ID: 11526920
    [No Abstract]   [Full Text] [Related]  

  • 68. Albumin utilization in cardiac surgery after transition to hydroxyethyl starch 130/0.4.
    Romerill DB; Toyoda AY; Brodeur BE; Moellentin D
    J Pharm Pract; 2012 Dec; 25(6):606-10. PubMed ID: 22797837
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Starch solutions in Australia: the empire strikes back.
    Bellomo R
    Crit Care Resusc; 2013 Dec; 15(4):253-4. PubMed ID: 24289503
    [No Abstract]   [Full Text] [Related]  

  • 70. [Volume replacement and coagulation impairment].
    Levi M; De Jonge E
    Minerva Anestesiol; 2005 Dec; 71(12 Suppl 1):11-6. PubMed ID: 16434957
    [No Abstract]   [Full Text] [Related]  

  • 71. Use of hetastarch for volume expansion.
    Iacono RP; Linford J
    J Neurosurg; 1987 Apr; 66(4):635-7. PubMed ID: 2435868
    [No Abstract]   [Full Text] [Related]  

  • 72. Tetrastarch solutions: are they definitely dead?
    Moral V; Aldecoa C; Asuero MS
    Br J Anaesth; 2013 Sep; 111(3):324-7. PubMed ID: 23946355
    [No Abstract]   [Full Text] [Related]  

  • 73. [EMA-decision on HES-restrictions].
    Svensén C; Hjelmqvist H
    Lakartidningen; 2014 Jan 8-14; 111(1-2):20. PubMed ID: 24498715
    [No Abstract]   [Full Text] [Related]  

  • 74. Should clinical studies guide clinical practice?
    Hartog C
    Swiss Med Wkly; 2012; 142():w13657. PubMed ID: 22847777
    [No Abstract]   [Full Text] [Related]  

  • 75. Anaphylactoid reaction to pentastarch.
    McHugh GJ
    Intensive Care Med; 1999 Jul; 25(7):767-8. PubMed ID: 10470588
    [No Abstract]   [Full Text] [Related]  

  • 76. EMA recommendation to suspend HES is hazardous.
    Annane D; Fuchs-Buder T; Zoellner C; Kaukonen M; Scheeren TWL
    Lancet; 2018 Feb; 391(10122):736-738. PubMed ID: 29449011
    [No Abstract]   [Full Text] [Related]  

  • 77. Anaphylaxis to starch.
    Ebo DG; Schuerwegh A; Stevens WJ
    Allergy; 2000 Nov; 55(11):1098-9. PubMed ID: 11097329
    [No Abstract]   [Full Text] [Related]  

  • 78. Persistent itching due to etherified starch plasma expander.
    Speight EL; MacSween RM; Stevens A
    BMJ; 1997 May; 314(7092):1466-7. PubMed ID: 9167566
    [No Abstract]   [Full Text] [Related]  

  • 79. NHS should ban use of starch based intravenous fluids, say researchers.
    Wise J
    BMJ; 2013 Feb; 346():f1323. PubMed ID: 23447423
    [No Abstract]   [Full Text] [Related]  

  • 80. [Not Available].
    Hahn R
    Lakartidningen; 2018 May; 115():. PubMed ID: 29738050
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.